Latest News and Press Releases

Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow.

Bionano announces a record 39 scientific presentations and posters highlighting optical genome mapping at two upcoming global cytogenetics conferences.

Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet

Optical genome mapping was used in three publications to successfully assess genome integrity in stem cells, CAR-T cells, and iPSCs.

Bionano announces significant advancements to its suite of computational tools for comprehensive cancer analysis.

Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1 2024, which represents a 34% increase over Q1...

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern...

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC...

Researchers used Cas9-directed Nanopore sequencing to validate structural variants detected by optical genome mapping in leukemia samples.

Bionano and Diagens form strategic partnership to commercialize OGM plus AI cytogenetic analysis for reproductive health in China.